In a first-of-its-kind prosecution, federal prosecutors have charged two healthcare executives with unlawfully distributing controlled substances, such as Adderall, through…
Read More →
New cybersecurity legislation to enhance the protection of computer systems of critical infrastructures (“CIs”) was proposed by the Hong Kong…
Read More →
The U.S. Food and Drug Administration (FDA) issued a long-anticipated draft guidance on June 26, 2024, entitled “Diversity Action Plans…
Read More →
Precedential and Key Federal Circuit Opinions – BETEIRO, LLC v. DRAFTKINGS INC. [OPINION] (2022-2275, 06/21/2024) (Dyk, Prost, Stark) – Stark,…
Read More →
The United States (US) has seen an explosion of litigation in recent years relating to perfluoroalkyl and polyfluoroalkyl substances (PFAS),…
Read More →
On July 2, 2024, CF Arcis XII, LLC dba Arcis Golf (“Arcis”) filed a notice of data breach with the…
Read More →
In a recent decision in Wong Sin Yi v. Kwan Pui Wing and The Kowloon Motor Bus Company (1933) Limited…
Read More →
In April 2024, Robins Kaplan attorneys secured a groundbreaking $7.75 million verdict against CRC Industries, Inc., a manufacturer of aerosol…
Read More →
Manufacturers, distributors, and retailers of consumer products across a broad spectrum of industries are being impacted by laws regulating the…
Read More →
When it comes to ensuring that data is preserved and available for litigation, investigations, or government inquiries, it all starts…
Read More →